I remember sitting in a biology class years ago, looking at diagrams of simple chemical pills and thinking that was the peak of medicine. You take a tablet, it dissolves, and you feel better. But lately, the conversation has shifted toward something much more complex and, frankly, a lot more exciting. We’ve entered a phase where we aren’t just using
Look, the whole healthcare world is moving, perpetually. And with that movement, the legal frameworks governing how we, as manufacturers, actually make and then get to market these therapeutic products are changing. The biggest change, the one you absolutely cannot ignore, is the Therapeutic Products Bill (TPB). It reconstructs, fundamentally, how every single natural health product (NHP) is now going
The rise of advanced therapeutics—biologics, peptides, antibody-drug conjugates (ADCs), cell-based treatments, and gene therapies—has revolutionized modern medicine. Their complexity and sensitivity make them highly susceptible to degradation, particularly from residual contaminants like hydrogen peroxide used during sterilization. Maintaining quality in therapeutic manufacturing isn’t just about compliance; it’s about ensuring patient safety and product efficacy. Pharma companies providing CDMO pharma services
Windlas Biotech Limited: Pioneering Pharma Solutions Globally | Empowering Healthier Lives | Authenticity and Affordability Redefined
Copyright ©2024 Windlas. All Rights Reserved.
©2023 Windlas. All Rights Reserved.
Empowering innovation at Windlas Biotech – where advanced research meets sustainable solutions. Driven by science, we are dedicated to transforming health through pioneering biotech advancements and excellence in research and development.
